144 related articles for article (PubMed ID: 28070874)
1. Infection of defective human T-lymphotropic virus type 1.
Hashikura Y; Umeki K; Umekita K; Nomura H; Yamada A; Yamamoto I; Hasegawa H; Yanagihara K; Okayama A
Hum Cell; 2017 Apr; 30(2):117-123. PubMed ID: 28070874
[TBL] [Abstract][Full Text] [Related]
2. The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.
Hashikura Y; Umeki K; Umekita K; Nomura H; Yamamoto I; Hasegawa H; Yanagihara K; Okayama A
Hum Cell; 2016 Jul; 29(3):122-9. PubMed ID: 26940204
[TBL] [Abstract][Full Text] [Related]
3. p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells.
Orita S; Kobayashi H; Aono Y; Saiga A; Maeda M; Igarashi H
Nucleic Acids Res; 1993 Aug; 21(16):3799-807. PubMed ID: 8367298
[TBL] [Abstract][Full Text] [Related]
4. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
[TBL] [Abstract][Full Text] [Related]
5. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
6. Construction of a full-length human T cell leukemia virus type I genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction.
Ohsugi T; Kumasaka T; Urano T
Anal Biochem; 2004 Jun; 329(2):281-8. PubMed ID: 15158488
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs.
Tanaka M; Sun B; Fang J; Nitta T; Yoshida T; Kohtoh S; Kikukawa H; Hanai S; Uchida K; Miwa M
J Virol; 2001 May; 75(9):4420-3. PubMed ID: 11287593
[TBL] [Abstract][Full Text] [Related]
8. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
9. Integration of HTLV-1 provirus into mouse transforming growth factor-alpha gene.
Fang J; Kushida S; Feng R; Tanaka M; Kikukawa H; Kawamura T; Uchida K; Miwa M
Biochem Biophys Res Commun; 1997 Apr; 233(3):792-5. PubMed ID: 9168935
[TBL] [Abstract][Full Text] [Related]
10. Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.
Alais S; Mahieux R; Dutartre H
J Virol; 2015 Oct; 89(20):10580-90. PubMed ID: 26269171
[TBL] [Abstract][Full Text] [Related]
11. The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells.
Hamaia S; Cassé H; Gazzolo L; Duc Dodon M
J Virol; 1997 Nov; 71(11):8514-21. PubMed ID: 9343209
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
13. Random integration of HTLV-1 provirus: increasing chromosomal instability.
Ohshima K; Ohgami A; Matsuoka M; Etoh K; Utsunomiya A; Makino T; Ishiguro M; Suzumiya J; Kikuchi M
Cancer Lett; 1998 Oct; 132(1-2):203-12. PubMed ID: 10397475
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type I provirus and T-cell prolymphocytic leukemia.
Kojima K; Hara M; Sawada T; Miyata A; Saito H; Matsuo Y; Yasukawa M; Fujita S; Harada M
Leuk Lymphoma; 2000 Jul; 38(3-4):381-6. PubMed ID: 10830745
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a novel defective HTLV-I provirus and detection of a new HTLV-I-induced cellular transcript.
Kubota S; Furuta RA; Siomi H; Maki M; Hatanaka M
FEBS Lett; 1995 Nov; 375(1-2):31-6. PubMed ID: 7498474
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an infectious molecular clone of human T-cell leukemia virus type I.
Zhao TM; Robinson MA; Bowers FS; Kindt TJ
J Virol; 1995 Apr; 69(4):2024-30. PubMed ID: 7884847
[TBL] [Abstract][Full Text] [Related]
17. A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.
Takemoto S; Matsuoka M; Yamaguchi K; Takatsuki K
Blood; 1994 Nov; 84(9):3080-5. PubMed ID: 7949180
[TBL] [Abstract][Full Text] [Related]
18. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
Datta A; Silverman L; Phipps AJ; Hiraragi H; Ratner L; Lairmore MD
Retrovirology; 2007 Jul; 4():49. PubMed ID: 17634129
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Shimamoto Y; Kobayashi M; Miyamoto Y
Leuk Lymphoma; 1996 Jan; 20(3-4):207-15. PubMed ID: 8624458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
